Document is current
Any future updates will be listed below
-
Authors
Bertoli, Ryan
Cao, Dengchao
Tuckey, Olivia https://orcid.org/0009-0004-5455-7418
Gammell, Susannah https://orcid.org/0000-0003-0429-2189
Wokasch, Anthony
Chung, Yang Jo
Foulks, Jason M.
Aplan, Peter D. https://orcid.org/0000-0001-5686-9969
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (ZIA SC 010378, BC 010983)
US Sumitomo Pharma Oncology provided funding Do the Aplan lab for some in vivo studies
- License Information
-
More Information
Article History
Received: 20 December 2024
Revised: 23 May 2025
Accepted: 17 June 2025
First Online: 18 July 2025
Competing interests
: PDA receives royalties from the NIH Technology Transfer program for the invention of NHD13 mice, and received funding from Sumitomo Pharma Oncology, Inc. to support the in vivo studies. JF is an employee of Sumitomo Pharma Oncology, Inc.
